Funding

Researcher : Xabier Aguirre Ena

9 funding €1,457,024.00

data available since 2018

2022

TERAPIA BASADA EN NANOTRANSPORTADORES DE RNA PARA EL TRATAMIENTO DEL CANCER - NanoRC
€143,965.00
Identification of the epigenomic and transcriptomic alterations in the transformation of benign monoclonal gammapathies to symptomatic multiple myeloma.
€149,985.00
REMANENTES: Deciphering the epigenomic mechanisms of transformation from benign monoclonal gammopathies to symptomatic multiple myeloma
€72,924.00

2021

TOWARDS A NEW PARADIGM IN THE TREATMENT OF BLADDER CARCINOMA: THE COMBINATION OF AN EPIGENETIC AGENT AND AN IMMUNE CHECKPOINT INHIBITOR
€180,000.00

2020

Deciphering the role of transcription factors as chromatin modulators and drivers of lymphoid neoplasm
€101,875.00

2019

Precision medicine approach to target deregulated metabolism in multiple mieloma (PREMAMM)
€121,500.00

2018

The information on this page about projects and other funding data may not be exhaustive for reasons of confidentiality and intellectual and industrial property protection. If you need more complete information, please contact the institution.